Northpointe Capital’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
DSC
HRCM
TGM
PCM
Northpointe Capital's ACLS Position: Q2 2017 in Review
Northpointe Capital sold out of Axcelis (ACLS) in Q2 2017, closing a stake of 290,649 shares — an estimated $5.46M sold.
Northpointe Capital first reported a position in ACLS in Q4 2014 and held it in 9 quarters. The position peaked at $6.68M in Q4 2016. 130 funds tracked by Wall St. Rank hold ACLS as of Q2 2017.
- Northpointe Capital reported no remaining Axcelis position as of Q2 2017 after selling out during the quarter.
- Northpointe Capital sold 290,649 Axcelis shares in Q2 2017, an estimated $5.46M.
- Northpointe Capital first reported a position in Axcelis in Q4 2014 and held it in 9 quarters.
- Northpointe Capital's Axcelis position peaked at $6.68M in Q4 2016.
- 130 funds tracked by Wall St. Rank held Axcelis as of Q2 2017.
Based on Northpointe Capital's 13F filing for Q2 2017, filed 3 Aug 2017.